As of November 2024, Array BioPharma has a market cap of $1.05B. This makes Array BioPharma the world's 7648th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.30B | -9.55% |
2023 | $2.54B | -13.09% |
2022 | $2.92B | 23.20% |
2021 | $2.37B | -63.63% |
2020 | $6.52B | - |